Develogen AG (acquired by Evotec) Company
.jpeg)
Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States.
Industry:
AI for Longevity
Headquarters:
Göttingen, Niedersachsen, Germany
Zip:
11-50
Founded Date:
1997-01-01
Employees Number:
11-50
Acquisitions Number:
10
Investors Number:
61534271
Total Funding:
61534271
Estimated Revenue:
2010-07-14
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership